Steroid-sparing therapy important in pandemic, SECURE-IBD registry shows
By Mardi Chapman
21 May 2020
Findings from the SECURE-IBD registry confirm many of the observed risk factors for severe COVID-19 disease in the general population apply to patients with Crohn’s disease and ulcerative colitis. The data from 528 mostly white patients from 33 countries, published in Gastroenterology, showed older age, two or more comorbidities, and systemic corticosteroid use were associated ...